Regeneron Calls For More Government-Funding of Biologic Manufacturing While Defending High Industry Prices

 
• By Sarah Karlin-Smith
  
Regeneron's George Yancopoulos spoke about COVID-19 and drug pricing on 18 November. • Source: STAT Summit

More from Pricing Debate

More from Market Access